AFCR prioritizes funding innovative research to achieve equal access to effective and affordable cancer treatment, particularly for cancers prevalent in Asia. Through its BRACE Award Program, AFCR funds and accelerates the development of cancer therapies, such as cutting-edge immunotherapies for gastrointestinal cancers and CAR T Cell therapies for solid tumors. Donate now to support our fight against cancer.
Double your impact, because only together can we make progress!
Learn more about Double Your Impact campaign
To directly fund cancer research support, please click on the red button below
AFCR believes the best way to accelerate progress is through collaboration with the research community, the biotech industry and non-profits.
The BRACE Award plays a critical role in this mission by funding impactful research for early-stage biotech companies so that we can get more groundbreaking therapies to patients faster.
Watch AFCR Chairman Lance Kawaguchi‘s interview with Dr John Luk and Dr Dennis Wong from Arbele to discuss how the BRACE Award has been critical to their groundbreaking research on gastrointestinal cancers and share their journey as an early-stage biotech, as they take their drug from preclinical development to a proof of concept clinical trial.
